INS and obesity due to melanocortin 4 receptor deficiency: 32139381 32139381 Garvey WT et al (2020) Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized controlled trial.